Jan Trøst Jørgensen

12PUBLICATIONS
6CO-AUTHORS
PharmacogenomicsMolecular targetsGene and molecular therapyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 10, 2026
Individualized pharmacotherapy: background and development.

|May 04, 2026
FDA 2025 Cancer Drug Approvals: targeted therapy dominates.

|Nov 07, 2025
Companion diagnostics and HER2-targeted antibody-drug conjugates.

Jan Trøst Jørgensen, Kristian Egebjerg

|Jun 24, 2024
Twenty-five years with HER2 targeted therapy.

Jan Trøst Jørgensen

|Oct 28, 2023
The Different Roles of MET in the Development and Treatment of Cancer.

Jens Mollerup, Jan Trøst Jørgensen

Pageof 2